Thursday, August 02, 2012 7:10:06 AM
A. CFO JOYCE Sells 9,824 Of WATSON PHARMACEUTICALS INC
DATE TRANSACTION SHARES PRICE VALUE
8/1/12 Exercise* 13,250 $34.26 $453,997
8/1/12 Sale 9,824 $78.60 $772,166
B. Director KLEMA Sells 21,700 Of WATSON PHARMACEUTICALS INC
DATE TRANSACTION SHARES PRICE VALUE
7/31/12 Exercise* 21,700 $37.43 $812,188
7/31/12 Sale 21,700 $78.38 $1,700,846
[No link - secure site]
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
